the increase in total production cost, the company and subsidiary still could generate the Cash Margin which indicate that the Company was well in operation management. Net gain on foreign exchange rate
. - Interest income in Q2/2018 amounted 48.54 million baht increased by 29.77 million baht or 158.60% from 18.77 million baht in Q2/2017 due to increase in JV loan and the increase in intercompany interest rate
Tenor : 5 years Maturity Date : Within 2025 Interest Rate : 2.45% - 2.70% per annum Interest Payment Date : Semi-annually Credit rating : “AA" with a “Stable” outlook rated by TRIS Rating Co., Ltd. The
Securities) 20 (Derivatives) (Hedging) (Foreign Exchange Rate Risk) (USD) (USD) (Feeder Fund) / (Fund of Funds) (risk spectrum) 30 AIA-GCA 2 - - - ? - - / / / / - - 2 3 - / - (Derivatives) - (Derivatives
plants. 3.Other income increased from the quarter 3/2018 by Baht 21.71 million or 518.14%, the major increase came from export Baht 23.35 million export delivery charge. 4 . Cost of sales and installation
5.99 million baht).This was due to unrealized gain on short term of investment and interest income. Cost of Sales In 2019, the company had the cost of sales valued 1,053.37 million baht or 69.29% of sale
International Hospital” to the Group. The finance costs decreased in the amount of Baht 5.9 million or 15.3% which in line with the management of interest rate of long-term debts. - Income tax for Q1/2018 in the
which the interest rate is approximately 9%-10% per year. Moreover, the management structure is not appropriate; therefore, the joint venture company has high unnecessary human resource management expense
interest expense which the interest rate is approximately 9-10 percent per year. Moreover, the management structure is not appropriate; therefore, the joint venture company has high unnecessary human
contracts and gain from the disposal of ordinary shares in joint venture companies • EBITDA stood at THB 33mn (down 74.9% YoY) largely as a result of the increase in unrealised loss on exchange rate. EBITDA